leqephe_banner

68858-20-8 Fmoc-L-Val-OH

68858-20-8 Fmoc-L-Val-OH

Tlhaloso e Khutšoanyane:

Ponahalo Phofo e tšoeu ho isa ho e tšoeu
MF C20H21NO4
MW 339.39
Bohloeki 98+


Lintlha tsa Sehlahisoa

Boemo ba lipalangoang
E ka ba mocheso o tloaelehileng

Khothalletsa mokhoa oa ho romella
Ka moea Ka naha Ka leoatle

Boemo ba polokelo:
Lula sebakeng se lefifi, sepakapaka se se nang moea, mocheso oa kamore

Shelf bophelo
Hoo e ka bang lilemo tse 2

Bonyane Bonyane oa Odara:
1kg (puisano)

Setifikeiti:COA, ntlha e qhibidihang, SpecificRotation [α]D20                      

Re tla romella data efe kapa efe eo u e batlang.U ka bona data pele e le litšupiso.

Bakeng sa lihlahisoa tse ikhethileng, re romella lintlha tse ncha ka mor'a hore li tsoe.

D-Ls(tfa)-NCA (2)

Litlhaloso tse tšoanang

FMOC-L-Valine

N-FMOC-VAL-OH

N-FMOC-L-VAL

N-FMOC-L-VALINE N-(9-FLUORENYLMETHOXYCARBONYL)-L-VALINE

N-9-FLUORENYLMETHYLOXYCARBONYL-L-VALINE

N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-VALINE

N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-VALINE N-ALPHA-FMOC-L-VALINE

Ho paka ka hare

Hangata li sebelisetsoa ho paka phofo.E itšetlehile ka litlhoko tsa bareki.Ka hona, re bolelle seo u se batlang pele u paka haeba u na le likopo tse khethehileng.

Ho paka ka hare 2
Ho paka ka hare 1
Ho paka ka hare 3

ho phuthela ka ntle

1kg ho isa ho 25kg Ho paka ka ntle ho thata.'Me ho thata ho khaola le ho senya.E ka sireletsa lihlahisoa tsa hau ka ho phethahetseng.

Ho paka ka ntle 3
Ho paka ka ntle 2
Ho paka ka ntle 1

Lisebelisoa

68858-20-8 Fmoc-L-Val-OH ke e 'ngoe ea li-intermediate tsa Abaloparatide.

Pele ho tsohle, Abaloparatide e sebetsa ho laola metabolism le ho khothalletsa ho thehoa ha masapo ka ho khetha ka ho khetha mocha oa pontšo oa PTH1 mofuta oa 1 receptor (PTH1R).E eketsa haholo masapo a masapo mme e fokotsa kotsi ea ho robeha.Liphuputso li bontšitse hore ho banna ba nang le lefu la ho fokola ha masapo, phekolo ea Abaloparatide haholo le ka potlako e ntlafatsa BMD (tekanyo ea masapo a masapo) ea mokokotlo, molala oa botšehali, le noka eohle ha e bapisoa le placebo.

Ea bobeli, Abaloparatide e amohetsoe bakeng sa ho rekisoa ke US Food and Drug Administration (FDA) bakeng sa phekolo ea lefu la masapo ho basali ba postmenopausal ba kotsing ea ho robeha kapa ba sa kang ba arabela mahlahana a mang a phekolo.Ho phaella moo, sethethefatsi sena se boetse se bontšoa ho banna ba baholo bao phekolo ea phekolo ea testosterone e sa bontšoeng ho fokotsa kotsi ea mokuli ea ho robeha ha lesapo la mokokotlo le ho eketsa matla a masapo ho fractures ea letheka le e seng ea letheka.

Ha u sebelisa Abaloparatide, tekanyetso e khothalletsoang ke 80mcg e tsamaisoang ka tlas'a letlalo hang ka letsatsi.Haeba lijo tsa mokuli li sa lekane, khalsiamo le vithamine D li lokela ho tlatsetsoa.

Ka kakaretso, Abaloparatide e bontšitsoe hore e sebetsa hantle ho phekola lefu la ho fokola ha masapo 'me e sebelisitsoe haholo litabeng tsa bongaka.

lihlahisoa tse amanang

L-Val-OH D-Val-OH N-Me-D-Val-OH Pht-Val-OH
AC-Val-OH Boc-L-Val-OH Boc-D-Val-OH Boc-N-Me-Val-OH
Fmoc-D-Val-OH Cbz-L-Val-OH Cbz-D-Val-OH Cbz-Val-Val-OH

Ke Hobane'ng ha U Re Khetha

1. Mabapi le MOQ: Re ka e fetola ho latela tlhoko ea hau.
2. Mabapi le mohlala: Mohlala o hloka tefiso ea mohlala, e ka ba thepa ea ho bokella kapa u ka e lefa esale pele.
3. Mold workshop, e ka etsoa customized ho ea ka palo ea mehlala.
4. Re fana ka tšebeletso e molemohali.Sehlopha sa barekisi se nang le boiphihlelo se se se ntse se u sebeletsa.
5. Mabapi le phapanyetsano: Ka kopo romella lengolo-tsoibila kapa u qoqa le 'na ha u le bonolo.


  • E fetileng:
  • E 'ngoe:

  • Ngola molaetsa wa hao mona mme o re romele wona